We demonstrate herein that acute exposure to the TLR4 ligand LPS does not inhibit the ameliorative effects of IVIg or KM114 and that IVIg was able to ameliorate murine ITP in mice with functionally inactive TLR4. Here, TLR4 is linked to autoimmune thrombocytopenic purpura.